• Article highlight
  • Article tables
  • Article images

Article History

Received : 17-06-2021

Accepted : 27-08-2021



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 362

PDF Downloaded: 338


Get Permission Surana: Comparison of safety and efficacy of tranexamic acid, tranexamic acid with adrenaline, and adrenaline alone in wound infiltration locally for postoperative bleeding in total knee arthroplasty


Introduction

Total knee arthroplasty (TKA) is among the most commonly performed orthopedic procedures. With the aging of the population, increase in life expectancy, and our ability to more effectively manage comorbidities in the perioperative period, the number of people undergoing joint replacement surgery has been steadily increasing over the last decades and that trend is going to continue into the foreseeable future. Only in the US, it is estimated that by the year 2030 almost 3.5 million total knee arthroplasties will be performed annually.1

Orthopedic surgery accounts for a significant proportion of all perioperative packed red-blood-cell transfusions, with arthroplasty accounting for nearly 40% of transfusions in orthopedic patients.2 It is known that perioperative anemia and RBC transfusions are associated with increased healthcare resource utilization, hospital length of stay, delayed recovery, and higher rates of postoperative morbidity and mortality.3, 4 and its associated complications like transfusion-related haemolytic and non haemolytic reactions, the transmission of diseases, increased risk of infection.

Tranexamic acid intravenously has been extensively studied for reducing post-operative bleeding but its safety regarding venous thromboembolism is a matter of concern5 Direct local application may reduce systemic toxicity, topical application via haemovac drain has been reported with good results.6, 5 However there is not much data on peri-articular injection of tranexamic acid.6 The role of EPINEPHRINE in reducing post-operative bleeding has been reviewed lately.6, 5, 7, 8 In this double-blind study, we compared the effect of Trenexa, Adrenaline, and their combined effect on post-operative blood loss.

Since the pioneering work of Hiippala and Benoni and colleagues9, 10 many prospective randomized studies and meta-analyses have confirmed the effectiveness of TXA to reduce perioperative blood loss and the need for allogenic and autologous blood transfusion in patients undergoing TKA.11

To address this issue, studies to establish the safety and effectiveness of topical TXA administration have been conducted. The idea is to maximize drug concentration at the site of surgery by intraoperative local infiltration resulting in negligent systemic absorption12 and by doing so reducing or avoiding completely a generalized antifibrinolytic effect while retaining the beneficial effects of reducing blood loss.13 In a recently published meta-analysis of 14 randomized controlled trials (11 in knee replacement, two in hip replacement, and one in both) which investigated the effect of topical TXA on blood loss and rates of transfusion Alshryda and colleagues found that indirect comparison of placebo-controlled trials of topical and intravenous TXA indicates that topical administration is even superior to the intravenous route without any significant difference in complication rates.14

Tranexamic acid is an antifibrinolytic agent that inhibits the conversion of plasminogen to plasmin and also acts as a plasmin inhibitor thus result in the inhibition of breaking down of fibrin clots and stabilization of clot.13 Release of tourniquet results in tissue trauma which increases fibrinolysis and plasmin activation The Fibrinolysis peaks at six hours after surgery and maintains at a high rate for up to 18 hours after surgery. Thus, tranexamic acid used in this period can significantly reduce blood loss. TXA reduces blood loss approx. from 10% to 70%.13, 15, 16, 17, 18, 19, 20

Adrenaline exerts its pro-coagulant effect mainly by two aspects 1) it reduces platelet transport time in the spleen and increases platelet aggregation by alpha-adrenergic activity thus resulting in an instant increase in platelet concentration by 20 to 30%.15, 16 epinephrine can promote the release of multiple coagulation factors through beta-adrenergic activation such as fibrinogen.

Intra-articular injection during surgical closure has been recommended for decreasing blood loss following total knee arthroplasty. Adrenaline is associated with some complications like delayed wound healing, skin necrosis, haematoma, and deep vein thrombosis18, 19 and combined effects of TXA and ADRE reduces these effects.

Material and Methods

The study was conducted after obtaining institutional ethical committee approval as a randomized double-blind controlled study. Informed written consent was obtained from all patients after thorough explanation.60 patients of ASA gr 1,2, and 3 are included in the study (as elderly pts generally have high B. P and diabetes). Pts with uncontrolled HT, DM, anemia (Hb <9 gm%), cardiac pts (M.I, Arrhythmias), Asthma pts, Pts with h/o thrombo-embolism, or on anticoagulant therapy, and also pts of chronic renal failure are excluded from the study.

Pts are randomized into three Grps. of 20 pts each according to computer-generated random no, kept in separate sealed envelopes. Grp A: pts received TXA 1000 mg (10-15 mg /kg iv 10 ml) +NS10.0 ml to make it 20ml to be given intraarticular and periarticular by surgeons at the time of wound closure before deflation of tourniquet. Grp B: pts received TXA 1000 mg (10 ml) +Adre 1 ml (1:10,000) + NS 9 ml to make it 20 ml. Grp C pts received Adre 1 ml (1:10,000) +NS 19 ml to make it 20 ml.

An Anaesthetist not involved in the conduct of anaesthesia and post-operative management prepared the drugs and gave them to the surgeon to be given intraarticular and periarticular at the time of wound closure before deflation of tourniquet. A blind observer assessed the pts for postoperative bleeding in romovac drain in the first 24 hrs., fall in Hb levels, no. of blood transfusion required in 24 to 48 hrs. and any untoward effects like haemarthrosis, skin redness, necrosis, etc.

All pts were undergone PAC before surgery which included thorough history, GPE, systemic examination, routine investigation including complete hemogram, platelet count, coagulation profile, E.C.G, X-ray chest, S Urea, Cr, and any specific investigation required before surgery. Pts with Hb < 9gm % raised urea- Cr were excluded from the study. All pts were given Spinal Anaesthesia for surgery.

Pts were given 1lit of RL/Ns before the conduct of anaesthesia. Monitoring of Pts started after shifting to O.T., which included B.P. ECG, oxygen saturation (Sp02). After proper painting and draping spinal anaesthesia was given at L2-L3 or L3-L4 space with all aseptic precautions in sitting position. Inj. Bupivacaine with or without Tramadol was given by Intrathecal route to provide anaesthesia for 3 to 4 hrs. All pts after turning supine were given Inj. Mephentermine 6 mg as prophylactic and further 6 mg were given if there is a fall in B. P< below 90 mm of Hg or a fall of > 30mm of Hg. Pts were given either RL or NS usually 1000 to 1500 ml (10-15 ml /kg/hr.)

Sample size calculation

We followed the pilot study13 in which they calculated a sample size based on the measured postoperative blood loss. They assumed an alpha error of 0.05 and applied an allocation ratio of 1. A sample size of 30 participants, which allowed a dropout rate of 10% (3 participants) was calculated to provide an 80% power in detecting a difference of 100-150 ml or reducing postoperative blood loss by 30%in favor of the peri-articular TXA injection. We divided pts into three groups of 20 pts each as we were comparing two drugs individually and their combined effect. All statistical analyses were performed using SPSS software version 17.0 (SPSS Inc, Chicago, IL, USA). Differences in categorical variables were analyzed by chi-square or Fisher’s exact test, as necessary, and the unpaired ‘t’ test was used for normally distributed continuous variables.

Table 1

Demographic data

Particulars

Group A

Group B

Group C

P-value

Mean

Std

Mean

Std

Mean

Std

Weight

55.18

14.57

60.5

12.9

58.3

12.4

 0.6418

Age

60.15

7.6

58.46

9.3

59.25

10.2

0.8417

M/Fm Ratio

19:01

17:03

18:02

Heart Rate

90.36

5.35

91.46

4.38

90.59

4.35

0.7395

B.P(Sys)

96.56

25.55

98.23

24.9

99.45

12.3

0.9148

B.P(Dias)

80.35

13.56

78.45

12.6

81.59

14.9

0.7355

Hb Level

11.59

2.52

10.72

3.57

11.02

2.95

0.533

Table 2

Comparison of heart rate in the post-operative period

Hr.

Group A

Group B

Group C

P value

0

Mean

Std

Mean

Std

Mean

Std

0

92.16

3.61

90.05

2.56

91.59

3.5

0.1153

2

96.16

5.15

92.26

4.59

93.39

5.8

0.059

4

94.21

6.59

96.56

3.3

98.56

6.19

0.0541

6

104.52

13.37

96.66

14.06

92.26

14.56

0.0251

8

96.59

12.98

94.19

13.13

98.52

14.13

0.596

12

93.46

13.52

90.32

14.13

91.21

13.14

0.7545

16

91.59

14.16

93.39

13.45

94.21

14.67

0.8353

20

88.92

15.78

90.24

14.67

91.59

13.78

0.8496

24

90.45

13.86

91.56

13.12

92.22

14.11

0.9186

Table 3

Comparison of blood pressure in the post-operative period (systolic)

Group A

Group B

Group C

P-value

Hr.

Mean

std

Mean

Std

Mean

Std

0

102.59

5.591

110.59

13.12

96.55

10.95

0.0062

2

110.56

12.19

110.23

14.59

98.76

14.17

0.0117

4

94.56

5.16

93.16

3.13

90.65

3.36

0.0105

6

100.37

7.56

98.22

6.67

96.59

4.56

0.181

8

93.59

5.98

94.46

6.16

96.36

5.12

0.3075

12

1O9.21

14.56

110.42

12.56

112.56

13.24

0.7297

16

116.59

13.59

112.56

14.92

108.67

13.56

0.219

20

111.56

15.17

108.44

19.05

105.67

16.14

0.5466

24

116.34

15.67

110.56

13.75

112.46

17.56

0.5004

Table 4

Comparison of blood pressure in the post-operative period (diastolic)

Group A

Group B

Group C

P-value

Hr.

Mean

Std

Mean

Std

Mean

Std

0

80.15

12.19

76.95

13.57

82.19

13.33

0.4454

2

80.2

8.53

76.53

9.56

80.46

10.15

0.345

4

76.25

7.15

74.58

5.76

72.36

8.12

0.2274

6

74.55

13.56

74.36

14.24

70.56

14.34

0.6013

8

76.21

14.63

78.15

14.78

70.48

14.78

0.2394

12

84.32

14.59

80.36

13.96

74.44

14.12

0.0959

16

88.1

13.62

82.15

14.05

76.12

13.78

0.0293

20

88.45

15.73

84.36

15.5

78.2

14.16

0.1074

24

90.15

14.12

88.42

14.19

78.76

13.78

0.0276

Table 5

Hb levels and fall in Hb levels

Group A

Group B

Group C

P-value

Mean

Std

Mean

Std

Mean

Std

Hb (Pre-operative)

11.59

2.52

10.72

3.56

11.02

2.95

0.7143

Hb (Post-Operative)

4hr

11.01

2.46

10.76

3.05

10.15

2.56

0..5400

24hrs

9.45

2.22

9.54

2.45

8.5

1.97

0.2687

Fall from post-operative Levels

1.56

0.3

1.22

0.45

1.65

0.68

0.0219

Fall from pre-operative Levels

2.14

0.3

1.18

1.11

2.52

0.19

0.005

Table 6

Blood loss in 24 hrs.

Group A

Group B

Group C

P-value

Hr.

Mean

Std

Mean

Std

Mean

Std

0-2

90.76

10.8

88.4

11.21

94.56

10.77

0.2076

.2-4

100.6

13.6

90.56

14.3

106.46

12.56

0.0018

.4-6

70.56

13.56

64.54

11.67

80.56

14.54

0.0014

.6-8

52.5

15.23

50.12

15.14

64.36

16.36

0.0119

.8-12

30.76

28.59

30

27.23

44.18

30.21

0.2247

.12-24

30.54

10.56

30.12

8.93

34.12

11.23

0.4069

Total Blood Loss in 24 hrs.

24

370.76

72.6

324.54

81.93

.410.35

88.23

0.0005

Figure 1

Percent of patients requiring blood transfusion

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/f36f306b-d81e-4611-bbba-b1f6c67d677b/image/6432981b-ff46-4278-875a-45ee226f2720-uimage.png

Observations

There was not much difference in demographic data as observed pre-operatively and is not significant statistically. (P value>0.05) Duration of surgery was also within 90 to 120 min, well done under required tourniquet time, only in 2 pts Surgery was prolonged hence we have to remove the tourniquet and reapply it but still, blood loss was not much and no pt. was given an intraoperative blood transfusion. Post-operatively HR and B.P were comparable in all the three Grps. in 0-4 hrs. but in 4 -8 hrs. HR and B.P was more stable in Grp B (96.66, 108/76;96.56,110/72 ;97.19, 112/76) as compared to Grp A (106.21, 100/72; 104.52, 102/68; 110,100/68) and Grp C(98.56 90.5/74,92.26 96/70,98.52 96/70 which was statistically significant. (P-Value 0 0.054, 0.011; 0.025, 0.010;) After that it was not comparable and non-significant statistically (P-value > 0.05,0.596,0.185;0.835,0.305) Fall in Hb level was also less in Grp B (1.22+-0.45), as compared to Grp A (1.56±0.3) and Grp C(1.65±0.68) at 4 hrs. post-operative and it was statistically significant (P-value 0.0219). Total 24 hrs. fall in Hb was 2.14±0.31 in Grp A, 1.18±1.14 in Grp B, and 2.52+-0.19in Grp C which was also statistically significant (P-value 0.005). as shown in Table 5 The total loss of blood in 0-2 hrs. was 90.76ml in Grp A, 96.6 ml in Grp B and110.6 ml in Grp C. In 2-4 hrs. it is 100ml in Grp A, 84.56 ML IN Grp B, and 130.59 ml in Grp C which was statistically significant. (P value0.0018) The total blood loss in 24 hrs. is 324±81.93ml in Grp B, 370±72. ±72.6 ml in Grp A and 410.30 ml in Grp C which was statistically significant (P value0.005). The no of blood transfusions required in 48 hrs. is 5 Units in Grp C as compared to 3 units in Grp A and 2 units in Grp B. This shows that local infiltration of TXA is effective in reducing postoperative blood loss and the addition of Adrenaline to TXA further helps in reducing the blood loss we didn’t observe any untoward effects like pulmonary embolism, DVT, but we didn’t perform any radiological or haematological interventions as no pts showed any clinical sign and symptoms. Adrenaline infiltration caused mild tachycardia and rise in B.P but that was transient and lasted only for 5-10 min

Discussions

Total knee arthroplasty is an effective treatment for osteoarthritis of the knee. We have seen that pts requiring TKA are elderly (average age ranges from 60-65yrs) and it’s a major surgery associated with substantial blood loss, which delays wound healing and may require post-operative allogenic blood transfusion which has complications like allergic reactions, haemolytic or non haemolytic febrile reactions, transfusion-related ALI, Graft Vs host disease, immune-related transfusion reaction, etc. Also, there is an impact on the liver, and chances of transmission of diseases are also there. This blood loss in the post-operative period is there even after improvement in surgical techniques and a decrease in operative time. This necessitates the proper effective and safe measures to reduce post-operative bleeding which helps in early ambulation of these pts and thus reduces morbidity & mortality and decreases the hospital stay time. Many methods have been proposed to reduce perioperative blood loss and preserve haemodynamic stability in these pts. There are various methods of blood loss reduction Antifibrinolytics, Fibrin Glue, Thrombin –Gelatin Mixture, Factor 8 Concentrate21, 22 but none is very established and they are expensive also. Local infiltration of TXA is a safe and inexpensive one and require not much expertise.

Lin et al.23 recently published an interesting study introducing the concept of combining two modes of TXA administration. They randomized 120 patients undergoing primary TKA into three groups. One group received a single 1.0 g dose of TXA in 20 mL saline intra-articularly after joint capsule closure (topical group); the second group received a combination of intravenous injection of 1.0g TXA 15 minutes before skin incision followed by local intra-articular application of 1.0 g after joint capsule closure, and the third group received only 20 mL normal saline by local intraoperative infiltration (control group). Outcome parameters were postoperative hemoglobin levels, Hb drop calculated as the difference between preoperative and Hb values at postoperative days 1 and 3, total drain amount at24 h after surgery, calculated total blood loss and transfusion rate. As expected, the mean total blood loss was significantly lower in both the topical and combined groups compared to placebo (705.1±213.9 vs. 578.7±246.9 vs. 948.8±278.5 ml, respectively; P<0.001) as was total drain amount (110.9±61.3vs. 56.8±34.6 vs. 211.9±121.9 mL; P<0.001). There was also a significant difference in transfusion rates when comparing the two TXA groups to controls (3 vs. 0 vs. (12.5±79.1 vs. 0 vs. 62.3±167.4 mL; P=0.008). There was no significant difference when comparing mean total blood loss among the two TXA groups although there is a trending favor of the combined regimen (P=0.063). The same holds when comparing transfusion rates.

Tranexamic Acid is a synthetic analogue of amino acid Lysine that inhibits fibrinolysis thus decreasing blood loss. It is a competitive inhibitor of plasminogen activation and at much higher conc. is a noncompetitive inhibitor of plasmin. Thus, it inhibits fibrinolysis and prevents the breakdown of clots, and reduces blood loss. Intravenous TXA has a proven track record in various surgeries like TKA, THA, Spine surgery 12, 13, 24, 16, 17, 18

There are various studies conducted on local infiltration of TXA in TKA, Comparison of local Vs intravenous TXA.13 A comparison of TXA and ADRE for local infiltration was done in a study recently and they found encouraging results. They used TXA 3 gm locally for intraarticular and periarticular inj. and compared it with local ADRENALINE inj. 1:2,00,000(1 ml adre 1:1000 dissolved in 200 ml of NS) and found a significant reduction in postoperative blood loss and transfusion requirements.1, 2, 3, 4, 6, 5 In another study, local infiltration was found better than intravenous and is associated with increased efficiency and fewer side effects.20, 25 Drakos et al. in 2016 gave 3 gm. of TXA in intertrochanteric fractures treated with intramedullary nailing. They found a 43% reduction in transfusion requirements.26

In the present study, we compared the haemostatic effects of TXA and Adrenaline alone and in combination. We found there is a significant reduction in postoperative bleeding in Grp A (TXA alone) and also effect was better when we combined the TXA and ADRE (Grp B) as compared to Grp C (ADRE alone). Total blood loss in 24 hrs. was 370.76 ml in Grp A, 324.54 ml in Grp B, and 410.30 ml in Grp C, which was statistically significant (P-value 0.005). Also, pre-operative Hb levels were 11.59±2.52,10.72±3.56 and 11.02±2.95, in the three groups and were statistically insignificant. (P-value 0.5333). post-operative fall in Hb level was 2.14±0.3gm% in Grp A, 1.18±1.1 gm % in Grp B, and 2.52±0.19gm% in Grp C, which was also statistically significant. (P-value 0.005). In our study pts were haemodynamically stable except 4 pts. in Grp C who had significant blood loss and had tachycardia, this indicates that infiltration of Adrenaline alone is not very effective but when given with TXA as adjuvant it increases its clot stabilizing effect.5 Adrenaline is associated with some untoward effects like haemarthrosis, redness, and skin necrosis at the site of injection15, 19 but we didn’t notice any untoward incidence and there was no sign of any DVT in any pts as we gave low molecular weight heparin subcutaneous to all pts 6hrs after surgery and continued 12hrly for 5days and lower limb muscle contraction exercises were initiated as soon as possible after the surgery. Blood transfusion was made only when Hb levels were below 8 or 8.5 gm/dl and pts within Hb levels of 8-10 gm/dl were observed for other signs like tachycardia, palpitation dizziness, etc. If these signs are present and blood loss was significant or the age of the pt. is above 65 pts were given transfusion even at a higher Hb level.

Conclusions

By studying the work done by other authors and analyzing our data we came to the conclusion that TXA given as local infiltration is an effective and safe method of preventing postoperative blood loss and the addition of Adrenaline as an adjuvant further adds to its effect without much untoward effect.

Drawbacks

In our study, the sample size selected is small hence not able to establish the effects. Therefore we suggest further studies on a large sample size. Also, we followed pts. for 48hrs. Only hence not able to detect untoward effect after 48hrs.

Financial Support and Sponsorship

Nil.

Conflicts of Interest

Nil.

References

1 

DR Spahn Anemia and patient blood management in hip and knee surgery: a systematic review of the literatureAnesthesiology2010113248295

2 

MR Rasouli LS Gomes B Parsley W Barsoum H Bezwada J Cashman Blood conservationJ Arthroplasty2014296570

3 

J Parvizi S Chaudhry MR Rasouli L Pulido A Joshi JH Herman Who needs autologous blood donation in joint replacement?J Knee Surg20112412531

4 

M Greenky J Shaner MR Rasouli SB Han J Parvizi WJ Hozack Intraoperative blood salvage in revision total hip arthroplasty: who benefits most?J Arthroplasty20142961298300

5 

A Amin A Watson J Mangwani DH Nawabi R Ahluwalia M Loeffler A prospective randomized controlled trial of autologous re-transfusion in total knee replacementJ Bone Joint Surg Br20089044514

6 

P Perazzo M Vigano L De Girolamo F Verde A Vinci G Banfi Blood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of preoperative autologous blood donationBlood Transfus20131133706

7 

VK Rao R Dyga C Bartels JH Waters A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplastyTransfusion2012528175060

8 

N Rosencher HE Kerkkamp G Macheras LM Munuera G Menichella DM Barton Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: Blood management in elective knee and hip arthroplasty in EuropeTransfusion200343445969

9 

R Slappendel R Dirksen EW Weber DB Van Der Schaaf An algorithm to reduce allogeneic red blood cell transfusions formal or orthopedic surgeryActa Orthop Scand200374556975

10 

G Benoni H Fredin Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized, double-blind study of 86 patientsJ Bone Joint Surg Br199678343440

11 

F Gao W Sun W Guo Z Li W Wang L Cheng Topical administration of tranexamic acid plus diluted-epinephrine in primary total knee arthroplasty: a randomized double-blinded controlled trialJ Arthroplasty201530813548

12 

AG Georgiadis SJ Muh CD Silverton RM Weir MW Laker A prospective double-blind placebo-controlled trial of topical tranexamic acid in total knee arthroplastyJ Arthroplasty2013288 Suppl7882

13 

R Gandhi HM Evans SR Mahomed NN Mahomed Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysisBMC Res Notes20136184

14 

J Cid M Lozano Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trialsTransfusion200545813027

15 

G Gasparini P Papaleo P Pola S Cerciello E Pola C Fabbriciani Local infusion of norepinephrine reduces blood losses and need of transfusion in total knee arthroplastyInt Orthop20063042536

16 

L Zhaohui G Wanshou Z Qidong Z Guangduo Topical hemostatic procedures control blood loss in bilateral cemented single-stage total knee arthroplastyJ Orthop Sci20141994853

17 

JH Park MR Rasouli SM Mortazavi AT Tokarski MG Maltenfort J Parvizi Parvizi Predictors of perioperative blood loss in total joint arthroplastyJ Bone Joint Surg Am20139519177783

18 

Q Wu HA Zhang SL Liu T Meng X Zhou P Wang Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trialsEur J Orthop Surg Traumato201525352541

19 

K Yamada T Imaizumi M Uemura N Takada Y Kim Comparison between 1-hour and 24-hour drain clamping using diluted epinephrine solution after total knee arthroplastyJ Arthroplasty20011645862

20 

GF Chimento T Huff JL Ochsner M Meyer L Brandner S Babin An evaluation of the use of topical tranexamic acid in total knee arthroplastyJ Arthroplasty2013288 Suppl747

21 

M Echave I Oyagüez MA Casado Use of Floseal (R), a human gelatin-thrombin matrix sealant, in surgery: a systematic reviewBMC Surg201414111

22 

J Astermark A Rocino MV Depka HMVD Berg A Gringeri LG Mantovani Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsHaemophilia20071313845

23 

SY Lin CH Chen YC Fu PJ Huang JK Chang HT Huang The Efficacy of Combined Use of Intraarticular and Intravenous Tranexamic Acid on Reducing Blood Loss and Transfusion Rate in Total Knee ArthroplastyJ Arthroplasty201530577680

24 

ZG Yang WP Chen LD Wu Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a metanalysisJ Bone Joint Surg Am2012941311539

25 

J Tan H Chen Q Liu C Chen W Huang A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplastyJ Surg Res201318428807

26 

A Drakos V Raoulis K Karatzios N Doxariotis V Kontogeorgakos K Malizos Efficacy of local administration of Tranexamic Acid for blood salvage in patients undergoing intertrochanteric fracture surgeryJ Orthop Trauma201630840914



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.